References
- Cross A. J., Rossor M. Dopamine D1 and D2 receptors in Huntington's disease. Eur. J. Pharmacol. 1983; 88: 223–229
- Cross A. J., Crow T. J., Owen F. Post mortem studies of dopaminergic function in Schizophrenia. Dopaminergic systems and their regulation, G. N. Woodruff, J. A. Poat, P. J. Roberts, 1986; 273–284
- Goldstein M., Kuga S., Shimizu Y., Meller E. The pathophysiological functions mediated by D1 dopamine receptors. Advances in Experimental Medicine and Biology, G. R. Breese and, I. Creese, 1986; 189–195; 204
- Siever L. J., Kafka M. S., Targum S., Lake R. Platelet Alpha-Adrenergic Binding and Biochemical Responsiveness in Depressed Patients and Controls. Psychiatry Res. 1984; 11: 287–302
- Hornykiewicz O, Kish S. J. Biochemical Pathophysiology of Parkinson's Disease. Advances in Neurology, M. A. Yahr, K. J. Bergmann, 1986; 19–34; 45
- Mann J. J., Stanley M., McBride A., McEwen B. S. Increased Serotonin-2 and β-Adrenergic Receptor Binding in the Frontal Cortices of Suicide Victims. Arch. Gen. Psychiatry 1986; 43: 954–959
- Creese I., Snyder S. H. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-Spiroperidol binding. Eur. J. Pharmacol. 1979; 56: 277–281
- Buonamici M., Caccia C., Carpentieri M., Pegrassi L., Rossi A. C., Di Chiara G. D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol. 1986; 126: 347–348
- Costall B., Naylor R. J. A comparison of circling models for the detection of antiparkinson activity. Psychopharmacologia 1975; 41: 57–64
- Paxinos G., Watson C. The rat brain in stereotaxis coordinates. Academic Press, SidneyAustralia 1982
- Billard W., Ruperto V., Grosby G., Iorio L., Barnett A. Characterization of the binding of [3H]SCH 23390, a selective D-1 receptor antagonist ligand in rat striatum. Life Sci. 1985; 35: 1885–1893
- Creese I., Schneider R., Snyder S. H. 3H-Spiroperidol labels dopamine receptors in pituitary and brain. Eur. J. Pharmacol. 1977; 46: 377–281
- Yamamura H. T., Snyder S. H. Muscarinic cholinergic binding in rat brain. Proc. Natn. Acad. Sci. USA 1974; 71: 1725–1729
- Greengrass P., Bremner R. Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors. Eur.J.Pharmacol. 1979; 55: 323–326
- Perry B. D., U'Prichard D. C. [3H]Rauwolscine (α-Yohimbine): a specific antagonist radioligand for brain α-2-adrenergic receptors. Eur. J. Pharmacol. 1981; 76: 461–464
- Bylund D. B., Snyder S. H. Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol. Pharmacol. 1976; 12: 568–580
- Pedigo N. W., Yamamura H. I., Nelson D. L. Discrimination of Multiple [3H]5-Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain. J. Neurochem. 1981; 36: 220–226
- Munson P. J., Rodbard D. LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Analyt. Biochem. 1980; 107: 220–239
- McPherson G. A. Kinetic, EBDA Ligand, Lowry A Collection of Radioligand Binding Analysis Programs. Elsevier Science Publishers, Amsterdam 1985
- Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem. 1975; 24: 407–409
- Lowry O. H., Rosebrough M. J., Farr A. L., Randall R. J. Protein measured with the folin phenol reagent. J.Biol. chem. 1951; 193: 265–275
- Achilli G., Perego C., Ponzio F. Application of the dual cell coulometric detector; a method for analyzing monoamines and their metabolites. Analyt. Biochem. 1985; 149: 1–9
- Cash R., Ruberg M., Raisman R., Agid Y. Adrenergic Receptors in Parkinson's Disease. Brain Res. 1984; 322: 269–275